Medifast, Inc. (MED) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.87 -2.47%
EPS Growth %: -195.2%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -195.2%
Financial Fact:
Net income: 6.07M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q2 EPS of $0.38, $0.09 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $78.3 million versus the consensus estimate of $81.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
